CU20180048A7 - Método para inactivar xenoantígenos en tejidos biológicos - Google Patents

Método para inactivar xenoantígenos en tejidos biológicos

Info

Publication number
CU20180048A7
CU20180048A7 CU2018000048A CU20180048A CU20180048A7 CU 20180048 A7 CU20180048 A7 CU 20180048A7 CU 2018000048 A CU2018000048 A CU 2018000048A CU 20180048 A CU20180048 A CU 20180048A CU 20180048 A7 CU20180048 A7 CU 20180048A7
Authority
CU
Cuba
Prior art keywords
tissues
xenoantigins
inactivating
biological
treated
Prior art date
Application number
CU2018000048A
Other languages
English (en)
Other versions
CU24631B1 (es
Inventor
Alessandro Gandaglia
Filippo Naso
Original Assignee
Biocompatibility Innovation Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibility Innovation Srl filed Critical Biocompatibility Innovation Srl
Publication of CU20180048A7 publication Critical patent/CU20180048A7/es
Publication of CU24631B1 publication Critical patent/CU24631B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Abstract

<p>Un método para inactivar xenoantígenos en tejidos biológicos, particularmente en tejidos que se pueden usar para fabricar sustitutos bioprotésicos y/o en sustitutos bioprotésicos que ya están preparados y destinados para uso clínico humano o veterinario.<br /> Tal método implica las siguientes etapas: proporcionar una solución basada en compuestos fenólicos, compuestos polifenólicos o derivados de los mismos, para la inactivación de al menos parte de los epitopos xenogénicos de dichos tejidos; incubar las muestras a ser tratadas en las diversas soluciones basadas en fenoles/polifenoles en condiciones controladas; someter los tejidos tratados a una serie de lavados.</p>
CU2018000048A 2015-11-30 2016-11-25 Método para inactivar xenoantígenos en tejidos biológicos CU24631B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A006019A ITUB20156019A1 (it) 2015-11-30 2015-11-30 Metodo per l'inattivazione di xenoantigeni in tessuti biologici
PCT/EP2016/078898 WO2017093147A1 (en) 2015-11-30 2016-11-25 Method for inactivating xenoantigens in biological tissues

Publications (2)

Publication Number Publication Date
CU20180048A7 true CU20180048A7 (es) 2018-11-06
CU24631B1 CU24631B1 (es) 2022-12-12

Family

ID=55485194

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2018000048A CU24631B1 (es) 2015-11-30 2016-11-25 Método para inactivar xenoantígenos en tejidos biológicos

Country Status (19)

Country Link
US (1) US20180353647A1 (es)
EP (1) EP3383446B1 (es)
JP (1) JP7169645B2 (es)
KR (1) KR20180090816A (es)
CN (1) CN108367098B (es)
AU (1) AU2016363536B2 (es)
BR (1) BR112018011021B1 (es)
CA (1) CA3006234A1 (es)
CU (1) CU24631B1 (es)
DK (1) DK3383446T3 (es)
ES (1) ES2881603T3 (es)
IL (1) IL259591B (es)
IT (1) ITUB20156019A1 (es)
MX (1) MX2018006577A (es)
PL (1) PL3383446T3 (es)
RS (1) RS62100B1 (es)
RU (1) RU2754197C2 (es)
WO (1) WO2017093147A1 (es)
ZA (1) ZA201803786B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600115523A1 (it) * 2016-11-16 2018-05-16 Biocompatibility Innovation Srl Metodo per l'inattivazione ed il controllo di avvenuta inattivazione di xenoantigeni in alimenti di origine animale, particolarmente per latte e derivati, e in alimenti di origine vegetale, particolarmente per succedanei di latte a base di soia e/o riso
EP3972659A1 (en) 2019-05-22 2022-03-30 Biocompatibility Innovation Srl Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807463B2 (en) * 2000-01-25 2010-10-05 The Board Of Regents Of The University Of Nebraska Pre-transplant accommodated organs resistant to anti-donor immunity
US20040153145A1 (en) * 2002-11-26 2004-08-05 Clemson University Fixation method for bioprostheses
JP2007529278A (ja) * 2004-03-17 2007-10-25 レビビコア， インコーポレイテッド 機能的α１，３ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
BRPI0618485A2 (pt) * 2005-11-10 2012-05-08 Hills Pet Nutrition Inc método, composição e kit para melhorar à saúde da pele e/ou a qualidade da pelagem de um animal, meio para comunicar informação ou instruções, e, uso de uma composição
US20070282422A1 (en) * 2006-05-10 2007-12-06 Cook Incorporated Medical devices and methods for local delivery of elastin-stabilizing compounds
CN101366979B (zh) * 2008-09-03 2012-08-29 陕西瑞盛生物科技有限公司 一种组织补片及其制备方法
FR2947456B1 (fr) * 2009-07-06 2012-03-09 Univ Bordeaux 1 Procede d'inactivation d'au moins un agent pathogene dans un echantillon de plasma sanguin humain
IL210162A0 (en) * 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
JP2014516695A (ja) * 2011-05-18 2014-07-17 バトリックス・メディカル・インコーポレイテッド 血管安定化用被覆バルーン
RU2495928C2 (ru) * 2012-01-30 2013-10-20 Сергей Юрьевич Лешков Средство для стимуляции синтеза белков теплового шока hsp 70 в клетках человека и животных; косметическое средство для стимуляции репаративных процессов; косметическое средство для снижения побочных эффектов агрессивных косметологических процедур; биологически активная добавка; пищевой продукт; способ снижения побочных эффектов агрессивных косметологических процедур
ITPD20120029A1 (it) * 2012-02-09 2013-08-10 Alessandro Gandaglia Metodo per la rilevazione di uno xenoantigene in tessuti fissati usati come sostituti bioprotesici
US9795573B2 (en) * 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby

Also Published As

Publication number Publication date
CN108367098B (zh) 2021-06-11
WO2017093147A1 (en) 2017-06-08
IL259591B (en) 2022-04-01
US20180353647A1 (en) 2018-12-13
JP2019503821A (ja) 2019-02-14
AU2016363536B2 (en) 2021-04-01
RS62100B1 (sr) 2021-08-31
CU24631B1 (es) 2022-12-12
PL3383446T3 (pl) 2021-11-02
CA3006234A1 (en) 2017-06-08
BR112018011021B1 (pt) 2021-12-07
RU2754197C2 (ru) 2021-08-30
RU2018123621A (ru) 2020-01-09
EP3383446B1 (en) 2021-04-28
CN108367098A (zh) 2018-08-03
DK3383446T3 (da) 2021-07-26
ITUB20156019A1 (it) 2017-05-30
JP7169645B2 (ja) 2022-11-11
ZA201803786B (en) 2019-02-27
EP3383446A1 (en) 2018-10-10
RU2018123621A3 (es) 2020-04-10
IL259591A (en) 2018-07-31
MX2018006577A (es) 2018-09-05
AU2016363536A1 (en) 2018-06-28
BR112018011021A2 (pt) 2018-11-21
ES2881603T3 (es) 2021-11-30
KR20180090816A (ko) 2018-08-13

Similar Documents

Publication Publication Date Title
CO2017001035A2 (es) “2-(morfolin-4-il)-1,7-naftiridinas sustituidas, composiciones y combinaciones farmacéuticas que las comprenden, y compuestos intermediarios
CO2021005884A2 (es) Moduladores de la alfa-1 antitripsina
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CL2017000998A1 (es) Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida del grupo de inhibidores de la mitosis y la división celular, tal como fenamidona. (divisional solicitud 3272-2014)
EA201892680A1 (ru) Композиция для укрепления волос и способ укрепления волос
CL2009000600A1 (es) Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
ECSP21026021A (es) Moduladores de la expresión de pnpla3
CR20150604A (es) Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos
BR112017025711A2 (pt) ?composições, processo para preparação de siloxanos modificados por poliéter e uso das composições inovadoras?
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
NI201900096A (es) Moduladores de la expresión de pcsk9
CL2015002171A1 (es) Métodos de tratamiento de la dificiencia de hierro con pirofosfato férrico soluble.
ECSP20082339A (es) Moduladores de la expresión de apol1
BR112018009745A2 (pt) compostos heterocíclicos para o tratamento de doença
CU20180048A7 (es) Método para inactivar xenoantígenos en tejidos biológicos
BR112017020013A2 (pt) método para preparação de um substituto da pele, substituto da pele, substituto dérmico, enxerto, enxerto para uso, e kit para implementação do método
CL2021001246A1 (es) Moduladores de expresión irf5.
CL2021000125A1 (es) Mezclas herbicidas que contienen aclonifeno y cinmetilina
BR112015017837A2 (pt) composições e métodos para tratar cabelo danificado
CO2017011472A2 (es) Métodos de tratamiento de plantas de cultivo
CL2013000332A1 (es) Matriz impregnable de origen vegetal, animal o sintetica que contiene un compuesto antimicrobiano distribuido homogeneamente; procedimiento para impregnar un compuesto en una matriz; uso de dicha matriz para preparar soportes solidos de uso cosmetico, farmaceutico, medico o veterinario.
CL2019003172A1 (es) Brimonidina destinada al uso y diseño de ensayos clínicos para la atrofia geográfica debido a una degeneración macular asociada a la edad.
CL2015001646A1 (es) Agentes herbicidas que contienen aclonifeno